Kevin Kotler - Aug 6, 2021 Form 4 Insider Report for BIODELIVERY SCIENCES INTERNATIONAL INC (BDSI)

Role
Director
Signature
BROADFIN CAPITAL, LLC, By: /s/ Kevin Kotler, Kevin Kotler, Managing Member
Stock symbol
BDSI
Transactions as of
Aug 6, 2021
Transactions value $
$87,900
Form type
4
Date filed
8/10/2021, 06:19 PM
Previous filing
May 13, 2021
Next filing
Nov 9, 2021

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction BDSI Common Stock Options Exercise $0 +30K +0.64% $0.00 4.69M Aug 6, 2021 See footnote F1, F2, F3
transaction BDSI Common Stock Options Exercise $44K +15K +0.32% $2.93 4.7M Aug 10, 2021 See footnote F2, F3

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction BDSI Restricted Stock Units Options Exercise $0 -30K -66.67% $0.00 15K Aug 6, 2021 Common Stock 30K $0.00 See footnote F1, F2, F3
transaction BDSI Stock Options (right to buy) Conversion of derivative security $44K +15K $2.93 7.5K Aug 10, 2021 Common Stock 15K $2.93 See footnote F2, F3, F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The shares of common stock were acquired by the Reporting Person as a result of the vesting of Restricted Stock Units ("RSUs") granted to the Reporting Person on August 1, 2018 under the Issuer's 2011 Equity Incentive Plan, as amended. The remaining RSUs vest as follows: 15,000 RSUs vest in the first open window following the Company's 2022 Annual Meeting of Stockholders.
F2 300,000 shares of Common Stock are held in the account of Broadfin Holdings, LLC., a private investment fund, and are deemed to be beneficially owned by Kevin Kotler, managing member of Broadfin Holdings, LLC.
F3 4,400,689 shares of Common Stock are held in the account of Broadfin Healthcare Master Fund, Ltd., a private investment fund managed by Broadfin Capital, LLC, and may be deemed to be beneficially owned by Kevin Kotler, managing member of Broadfin Capital, LLC. Broadfin Healthcare Master Fund, Ltd., Broadfin Capital, LLC, and Kevin Kotler affirmatively (i) disclaim beneficial ownership of the reportable securities, (ii) states that this report shall not be deemed an admission that they are the beneficial owner of such securities for purposes of Section 16 ("Section 16") of the Securities Exchange Act of 1934, as amended (the "Act") or any other purpose, except to the extent of their pecuniary interest therein, and (iii) disclaim being a "group" for purposes of Section 16.
F4 The shares of common stock were acquired by the Reporting Person as a result of the exercise of stock options granted to the Reporting Person on August 1, 2018 under the Issuer's 2011 Equity Incentive Plan, as amended. The remaining options vest as follows: 7,500 options vest in the first open window following the Company's 2022 Annual Meeting of Stockholders.